EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes

Jenna B Shapiro iD, Anthony T Vesco, Michael S Carroll, Jill Weissberg-Benchell iD

Diabetes Technology & Therapeutics · 2024

DOI: 10.1089/dia.2024.0117 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Jenna B Shapiro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pritzker Department of Psychiatry and Behavioral Health, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemic Agents, Insulin, Insulin Infusion Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the psychometric properties of a patient-reported outcome measure, the Automated Insulin Delivery—Benefits and Burdens Scale (AID-BBS), which was designed to assess benefits and burdens of AID use in adults with type 1 diabetes (T1D). The measure was hypothesized to have validity, reliability, and clinical utility for predicting likelihood of continued use of an AID system. Research Design and Methods: A total of 217 adults with T1D (ages from 18 to 82 years) who were enrolled in an AID system research trial completed AID-BBS items at study midpoint (6 weeks) and at the end of the trial (13 weeks). Data were collected on pre-post glycemic outcomes. Participants completed other patient-reported psychosocial outcome measures (e.g., emotional well-being, diabetes distress, attitudes toward diabetes technology, diabetes treatment satisfaction) at Week 13. Likelihood of continued device use was assessed with three items at 13 weeks.

Results

Exploratory factor analysis supported a one-factor structure for each subscale (15-item benefit and 9-item burden subscale) when evaluated separately. Convergent, discriminant, and predictive validity, internal consistency, and test–retest reliability were supported. Benefit and burden subscales at week 6 predicted usage intention above and beyond device impact on glycemic outcomes, also controlling for baseline glycemic outcomes.

Conclusion

Findings support the AID-BBS as a psychometrically valid, reliable, and useful instrument for assessing burdens and benefits associated with AID system use in adults with T1D. The measure can be used to help health care providers set realistic expectations and proactively address modifiable burdens. Clinical Trial Registration Number: NCT04200313.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Hypoglycemic AgentsInsulinInsulin Infusion SystemsPatient Reported Outcome MeasuresPsychometricsAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultReproducibility of Results

Stichwörter der Autor:innen

artificial pancreasautomated insulin deliverybionic pancreasclosed-loop systemspatient reported outcomespsychosocialtype 1 diabetes

Substanzen

Hypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Pritzker Department of Psychiatry and Behavioral Health, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Mary Ann & J. Milburn Smith Outcomes Research and Evaluation Center, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Jenna B Shapiro, Jill Weissberg-Benchell

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Shapiro, J. B., Vesco, A. T., Carroll, M. S., & Weissberg-Benchell, J. (2024). Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0117

Vancouver

Shapiro JB, Vesco AT, Carroll MS, Weissberg-Benchell J. Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2024.0117

BibTeX
@article{Shapiro2024,
  author = {Shapiro, Jenna B and Vesco, Anthony T and Carroll, Michael S and Weissberg-Benchell, Jill},
  title = {Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2024},
  doi = {10.1089/dia.2024.0117}
}
Kostenlos starten →